glp-1 product Food makers warn GLP-1s will have 'lasting influence' on sector How GLP-1 drug use is

Noom can also help you create a personalized plan that works for you

The FDA has responded with three waves of enforcement letters - September 2025, March 2026, and June 2026 - targeting telehealth companies for misleading GLP-1 marketing

There are dramatic mortality reductions being shown for populations that are already taking these drugs for diabetes and obesity

Primarily, prescription drugs benefit from rigorous clinical validation, ensuring higher efficacy and safety profiles than Over-the-Counter (OTC) alternatives

The target cells include those in the satiety centers of the brain, which may explain the outsized weight loss

Sustainable weight maintenance is possible when therapy is paired with long-term nutrition and lifestyle support